VDP temporarily removed the non-preferred status for brand Concerta products in the Stimulants drug class on April 23 in response to reported drug shortages. VDP will reverse this change in status because of sufficient availability in the market. VDP made this determination after verifying the current availability of the preferred Methylphenidate ER tablet products, as well as the non-preferred brand Concerta products through multiple sources such as ASHP, FDA, manufacturers, wholesalers, and pharmacies in various regions around Texas.
VDP will restore the non-preferred status on the drugs below on Oct. 16 because of sufficient product availability. For a complete list of all preferred products in the Stimulants drug class, refer to the July 2020 Preferred Drug List. Contact email@example.com for questions or comments.
|50458058501||CONCERTA ER 18 MG TABLET|
|50458058801||CONCERTA ER 27 MG TABLET|
|50458058601||CONCERTA ER 36 MG TABLET|
|50458058701||CONCERTA ER 54 MG TABLET|